menu close
www.vesaliustx.com

Vesalius Therapeutics Stock

Company Profile:

Vesalius Therapeutics is a biotechnology company focused on developing innovative therapies for complex diseases by targeting the human transcriptome. The company uses cutting-edge RNA-based technologies to identify novel drug targets and create treatments that can address a range of diseases. Its mission is to advance precision medicine through the discovery of transformative therapeutic options.

Sign up for SecondMarket® to view the market and buy or sell Vesalius Therapeutics Stock
Buy + Sell
  • Headquarters: Cambridge, MA
  • Year Founded: 2018
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

Vesalius Therapeutics Management Team

  • Board Member

    Andrew Lo

  • Board Member

    Doug Cole

  • CEO, Board Member

    John D. Mendlein

  • Board Member

    Steven Hyman

Learn More About Vesalius Therapeutics Stock

Buy Vesalius Therapeutics Stock
01

Vesalius Therapeutics stock does not trade on public stock exchanges. Vesalius Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Vesalius Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Vesalius Therapeutics Stock
02

Vesalius Therapeutics Stock does not trade on public stock exchanges. In order to sell Vesalius Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Vesalius Therapeutics Stock Price
03

Vesalius Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Vesalius Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Vesalius Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for Vesalius Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Vesalius Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Vesalius Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Vesalius Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Vesalius Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Vesalius Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Vesalius Therapeutics IPO
08

Vesalius Therapeutics is a private company and has not had an IPO. There is currently no Vesalius Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Vesalius Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Vesalius Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Insitro-Logo

insitro

Drug discovery and development company.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Somatus-Logo

Somatus

Integrated care for patients with or at risk of developing kidney disease.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Source: Nasdaq Private Market Tape D®